Sensitivities of Uterine Adenocarcinoma, Mixed Mullerian Tumor (MMT) and Sarcoma Cell Lines to Chemotherapeutic Agents and a Flex-Het Drug

di Hyde, Johnny, Benbrook, Doris M.
Pubblicazione 2006

Targeting autophagy in cancer management – strategies and developments

di Ozpolat, Bulent, Benbrook, Doris M
Pubblicato in Cancer Manag Res (2015)

Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis

di Mic, Felix A., Molotkov, Andrei, Benbrook, Doris M., Duester, Gregg
Pubblicazione 2003

PHARMACOKINETICS AND PHARMACODYNAMICS OF ESCALATING DOSES OF SHetA2 AFTER VAGINAL ADMINISTRATION TO MICE

di Mahjabeen, Sanjida, Hatipoglu, Manolya Kukut, Benbrook, Doris M., Garcia-Contreras, Lucila
Pubblicato in J Pharm Sci (2018)

The Dawning of the Age of Personalized Medicine in Gynecologic Oncology

di Leslie, Kimberly K., Thiel, Kristina W., Benbrook, Doris M., Mutch, David
Pubblicato in Cancers (Basel) (2020)

Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia

di Mahjabeen, Sanjida, Hatipoglu, Manolya K., Chandra, Vishal, Benbrook, Doris M., Garcia-Contreras, Lucila
Pubblicato in J Pharm Sci (2017)

Nitroxoline (5-amino-8-hydroxyquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline)

di Jiang, Hongchao, Taggart, Jori E., Zhang, Xiaoxi, Benbrook, Doris M., Lind, Stuart E., Ding, Wei-Qun
Pubblicazione 2011

Physiologically Based Pharmacokinetic Modeling and Tissue Distribution Characteristics of SHetA2 in Tumor-Bearing Mice

di Sharma, Ankur, Li, Mengjie, Thavathiru, Elangovan, Ibrahim, Mariam, Garcia-Contreras, Lucila, Benbrook, Doris M, Woo, Sukyung
Pubblicato in AAPS J (2020)

Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo

di Myers, Tashanna, Chengedza, Shylet, Lightfoot, Stan, Pan, Yanfang, Dedmond, Daynelle, Cole, Lauren, Tang, Yuhong, Benbrook, Doris M.
Pubblicazione 2008

Gene Expression Analysis of Biological Systems Driving an Organotypic Model of Endometrial Carcinogenesis and Chemoprevention

di Benbrook, Doris M., Lightfoot, Stan, Ranger-Moore, James, Liu, Tongzu, Chengedza, Shylet, Berry, William L., Dozmorov, Igor
Pubblicazione 2008

Aberrant NRP-1 expression serves as predicator of metastatic endometrial and lung cancers

di Okon, Imoh S., Ding, Ye, Coughlan, Kathleen A., Wang, Qiongxin, Song, Ping, Benbrook, Doris M., Zou, Ming-Hui
Pubblicato in Oncotarget (2015)

Accelerated vascular aging and persistent cognitive impairment in older female breast cancer survivors

di Carlson, Barbara W., Craft, Melissa A., Carlson, John R., Razaq, Wajeeha, Deardeuff, Kelley K., Benbrook, Doris M.
Pubblicato in GeroScience (2018)

VAGINAL SUPPOSITORIES CONTAINING SHetA2 TO TREAT CERVICAL DYSPLASIA: PHARMACOKINETICS OF DAILY DOSES AND PRELIMINARY SAFETY PROFILE

di Mahjabeen, Sanjida, Hatipoglu, Manolya Kukut, Kosanke, Stanley D., Garcia-Contreras, David, Benbrook, Doris M., Garcia-Contreras, Lucila
Pubblicato in J Pharm Sci (2020)

Complementary Targeting of Rb Phosphorylation and Growth in Cervical Cancer Cell Cultures and a Xenograft Mouse Model by SHetA2 and Palbociclib

di Kennedy, Amy L., Rai, Rajani, Isingizwe, Zitha Redempta, Zhao, Yan Daniel, Lightfoot, Stanley A., Benbrook, Doris M.
Pubblicato in Cancers (Basel) (2020)

Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy

di Griffith, James, Andrade, Daniel, Mehta, Meghna, Berry, William, Benbrook, Doris M., Aravindan, Natarajan, Herman, Terence S., Ramesh, Rajagopal, Munshi, Anupama
Pubblicato in Oncol Rep (2017)

N-Acetylcysteine interacts with copper to generate hydrogen peroxide and selectively induce cancer cell death

di Zheng, Jie, Lou, Jessica R., Zhang, Xiao-Xi, Benbrook, Doris M., Hanigan, Marie H., Lind, Stuart E., Ding, Wei-Qun
Pubblicazione 2010

Heteroarotinoids with Anti-Cancer Activity Against Ovarian Cancer Cells

di Le, Thanh C., Berlin, K. Darrell, Benson, Stacy D., Eastman, Margaret A., Bell-Eunice, Gianna, Nelson, Anna C., Benbrook, Doris M.
Pubblicazione 2007

Novel ovarian cancer maintenance therapy targeted at mortalin and mutant p53

di Ramraj, Satish K., Elayapillai, Sugantha P., Pelikan, Richard C., Zhao, Yan D., Isingizwe, Zitha R., Kennedy, Amy L., Lightfoot, Stanley A., Benbrook, Doris M.
Pubblicato in Int J Cancer (2020)

Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen

di Doppalapudi, Rupa S., Riccio, Edward S., Davis, Zoe, Menda, Sean, Wang, Abraham, Du, Nicholas, Green, Carol, Kopelovich, Levy, Rao, Chinthalapally V., Benbrook, Doris M., Kapetanovic, Izet M.
Pubblicazione 2012

Loss of natural killer T cells promotes pancreatic cancer in LSL‐Kras(G12D/+) mice

di Janakiram, Naveena B., Mohammed, Altaf, Bryant, Taylor, Ritchie, Rebekah, Stratton, Nicole, Jackson, Lydgia, Lightfoot, Stan, Benbrook, Doris M., Asch, Adam S., Lang, Mark L., Rao, Chinthalapally V.
Pubblicato in Immunology (2017)